Skip to main content

Drugs Affecting Hair Growth

  • Chapter
Hair and Hair Diseases

Abstract

Several drugs are able to influence hair growth, resulting in hair loss (effluvium) or hypertrichosis. Clinical symptoms are the result of interactions between the drug and various cells important for hair growth, such as follicular keratinocytes, cells of the matrix, and those of connective tissue surrounding the bulb and perifollicular blood vessels. Especially the keratinocytes of the hair follicle are a major target for toxic effects by environmental agents or xenobiotics. One reason for this is that up to 90% of all hair follicles are in a phase of rapid growth, and the high blood flow rate around hair bulbs results in a good bioavailability of many compounds (Orfanos et al. 1976; Zaun 1986). Another reason may be that follicular keratinocytes are capable of much more enzymatic activity in metabolizing exogenous compounds than are other keratinocytes (Wattenberg and Leong 1970). This has been shown by the assessment of enzyme-dependent activities, by histochemical analysis and by immunofluorescent staining with monoclonal antibodies that react with cytochrome P-450 isoenzymes (Merk et al. 1984; Wattenberg and Leong 1970).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Bendtzen K (1984) Ciclosporin (Cyclosporin A): prototype of a new generation of immune suppressive drugs. Allergy 39:565–571

    Article  PubMed  CAS  Google Scholar 

  • Blankenship ML (1983) Drugs and alopecia. Aust J Dermatol 24:100–104

    Article  CAS  Google Scholar 

  • Boyd MR, Grygiel JJ, Miuchin RF (1983) Metabolic activation as a basis for organ selective toxicity. Clin Exp Pharmacol Physiol 10:87–99

    Article  PubMed  CAS  Google Scholar 

  • Braun-Falco O (1961) Klinik und Pathomechanismus der Endoxan-Alopecie als Beitrag zumv Wesen cytostatischer Alopecien. Arch Klin Exp Dermatol 212:194–216

    Article  Google Scholar 

  • Burton JL, Schutt WH, Caldwell IW (1975) Hypertrichosis due to diazoxide. Br J Dermatol 93:707–711

    Article  PubMed  CAS  Google Scholar 

  • Chytil F, Ong DE (1979) Cellular retinol- and retinoic acid-binding proteins in vitamin A action. Fed Proc 38:2510–2514

    PubMed  CAS  Google Scholar 

  • Cohen DJ, Loertscher R, Rubin MF, Tilney NL, Carpenter CB, Strom TB (1984) Cyclosporine: a new immunosuppressive agent for organ transplantation. Ann Intern Med 10:667–682

    Google Scholar 

  • Crounse RG, van Scott EJ (1960) Changes in scalp hair roots as a measure of toxicity from cancer chemotherapeutic drugs. J Invest Dermatol 35:83–90

    PubMed  CAS  Google Scholar 

  • De Luca LM, Bhat PV, Sosak W, Adams S (1979) Biosynthesis of phosphoryl and glycosyl phosphoryl derivatives of vitamin A in biological membranes. Fed Proc 38:2535–2539

    PubMed  Google Scholar 

  • Fiedler-Weiss VC, West DP, Buys CM, Rumsfield JA (1986) Topical minoxidil dose-response effect in alopecia areata. Arch Dermatol 122:180–182

    Article  PubMed  CAS  Google Scholar 

  • Franz TJ (1986) Percutaneous absorption of minoxidil in man. Arch Dermatol 121:203–206

    Article  Google Scholar 

  • Gerstein E, Orfanos CE (1976) Haarausfall nach Zytostatika. Ärztl Kosmetol 6:54–60

    Google Scholar 

  • Gollnick H, Schwarztkopf W, Pröschle W, Luley C, Schleising M, Mattheis E, Orfanos CE (1985) Retinoids and blood lipids: an update and review. In: Saurat JH (ed) Retinoids. Karger, Basel

    Google Scholar 

  • Hammond PB, Beliles RP (1980) Metals. In: Doull CJ, Klaassen CD, Amdur MO (eds) Toxicology. Macmillan, New York

    Google Scholar 

  • Headington JT, Novak E (1984) Clinical and histological studies of male pattern baldness treated with topical minoxidil. Curr Ther Res Clin Exp 36:1098–1106

    Google Scholar 

  • Hommes H (1983) Dacarbazin: Wirkungen auf Haarwurzeln, Blutbild und Leberenzyme. Thesis, University of Cologne

    Google Scholar 

  • Kiser J, Jung E, Salchi S, Heckendorn V, Brunner KW (1983) Der zytostatikabedingte Haarausfall. Schweiz Rundsch Med Prax 72:1289–1292

    PubMed  CAS  Google Scholar 

  • Ippen H (1970) Haarausfall durch Medikamente. Dtsch Med Wochenschr 95:1411–1416

    Article  PubMed  CAS  Google Scholar 

  • Levantine A, Almeyda J (1973) Drug induced alopecia. Br J Dermatol 89:549–553

    Article  PubMed  CAS  Google Scholar 

  • Melnik B, Plewig G (1986) Retinoide und Lipidstoffwechsel. Hautarzt 37:304–311

    PubMed  CAS  Google Scholar 

  • Merk H, Rumpf M, Bolsen K, Wirth G, Goerz G (1984) Inducibility of arylhydrocarbon-hydroxylase activity in human hair follicles by topical application of liquor carbonis detergens (coal tar). Br J Dermatol 111:279–284

    Article  PubMed  CAS  Google Scholar 

  • Merk H, Muhktar H, Kaufmann I, Das M, Bickers DR (1987) Human hair follicle carcinogen metabolism. J Invest Dermatol 88:71–76

    Article  PubMed  CAS  Google Scholar 

  • Novak E, Franz TJ, Headington JT, Wester RC (1985) Topically applied minoxidil in baldness. Int J Dermatol 24:83–87

    Article  Google Scholar 

  • Olsen EA, Weiner MS, Delong ER, Pinnel SR (1985) Topical minoxidil in early male pattern baldness. J Am Acad Dermatol 13:185–192

    Article  PubMed  CAS  Google Scholar 

  • Olsen EA, deLong ER, Weiner MS (1986) Dose response study of topical minoxidil in male pattern baldness. J Am Acad Dermatol 15:30–37

    Article  PubMed  CAS  Google Scholar 

  • Orfanos CE, Gerstein E (1976) Haarausfall und Zytostatika. Ärztl Kosmet 6:96–105

    Google Scholar 

  • Orfanos CE, Gerstein E, Runne U (1976) Der zytostatische Haarverlust als biologisches Modell. Dtsch Med Wochenschr 101:1466–1468

    PubMed  CAS  Google Scholar 

  • Paus R, Stenn KS, Link RE (1989) The induction of anagen hair growth in telogen mouse skin by cyclosporine A administration. Lab Invest 60:365–369

    PubMed  CAS  Google Scholar 

  • Reeves JRT, Maibach HI (1977) Drug and chemical induced hair loss. In: Marzulli FN, Maibach HI (eds) Dermatotoxicology and pharmacology. Halsred, New York

    Google Scholar 

  • Rook A, Dawber R (1982) Diseases of the hair and scalp. Blackwell, Oxford

    Google Scholar 

  • Steigleder GK (1978) Haut. In: Heintz R (ed) Erkrankungen durch Arzneimittel. Thieme, Stuttgart

    Google Scholar 

  • Steigleder GK, Mahrle G (1973) Haarausfall als polyätiologisches Symptom. Fortschr Prakt Dermatol Venerol 7:237–248

    Article  Google Scholar 

  • Sunderman FW (1967) Diethyldithiocarbamate therapy for thallotoxicosis. Am J Med Sci 253:209–220

    Article  CAS  Google Scholar 

  • Thomson AW, Whiting PH, Simpson JG (1984) Cyclosporine: immunology, toxicity and pharmacology in experimental animals. Agents Actions 15:306–327

    Article  PubMed  CAS  Google Scholar 

  • Tuchman M, Stoeckeler JS, Kiang DT, O’Dea ML, Ramnarine ML, Mirkin BL (1985) Familial pyrimidinemia and pyrimidinura associated with severe fluorouracil toxicity. N Engl J Med 313:245–249

    Article  PubMed  CAS  Google Scholar 

  • Vanderveen EE, Ellis CN, Kang S, Case P, Headington JT, Voorhees J, Swanson NA (1984) Topical minoxidil for hair regrowth. J Am Acad Dermatol 11:416–421

    Article  PubMed  CAS  Google Scholar 

  • Vesell ES (1979) Pharmacogenetics: multiple interactions between genes and environment as determinants of drug response. Am J Med 66:183–187

    Article  PubMed  CAS  Google Scholar 

  • Vesell ES (1984) Pharmacogenetic perspectives: genes, drugs, and disease. Hepatology 4:959–965

    Article  PubMed  CAS  Google Scholar 

  • Vesell ES, Penno MB (1983) Assessment of methods to identify sources of interindividual pharmacokinetic variations. Clin Pharmacokinet 8:378–409

    Article  PubMed  CAS  Google Scholar 

  • Vestey ES, Savin JA (1986) A trial of 1% minoxidil used topically for severe alopecia areata. Acta Derm Venereol (Stockh) 66:179–180

    CAS  Google Scholar 

  • Wattenberg W, Leong JC (1970) Benzpyrene hydroxylase in mouse skin. Proc Am Assoc Cancer Res 11:81

    Google Scholar 

  • Weiss VC, West DP (1985) Topical minoxidil therapy and hair regrowth. Arch Dermatol 121:191–192

    Article  PubMed  CAS  Google Scholar 

  • White SI, Friedmann PS (1985) Topical minoxidil lacks efficacy in alopecia areata. Arch Dermatol 121:591

    Article  PubMed  CAS  Google Scholar 

  • Zaun H (1986) Haarkrankheiten — Systematik, pathophysiologische Grundlagen, Differentialdiagnose. Therapiewoche 36:2695–2700

    Google Scholar 

  • Zaun H, Neumann K, Werner G (1972) Die Feinstruktur dystrophischer Haare bei Vitamin A- und Thallium-Intoxikation. Hautarzt 23:544–550

    PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Merk, H.F. (1990). Drugs Affecting Hair Growth. In: Orfanos, C.E., Happle, R. (eds) Hair and Hair Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74612-3_23

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-74612-3_23

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-74614-7

  • Online ISBN: 978-3-642-74612-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics